MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

C25-140

CAS No. : 1358099-18-9

MCE 站：C25-140

产品活性：C25-140 是一种首创的，具有口服活性和一定选择性的 TRAF6-Ubc13 相互作用的抑制剂，直接与 TRAF6 结合，阻断 TRAF6 和 Ubc13 的相互作用，从而降低 TRAF6 活性，降低 NF-κB 的活性，并对抗自身免疫。

研究领域：Apoptosis  |  Metabolic Enzyme/Protease

作用靶点：TNF Receptor  |  E1/E2/E3 Enzyme

In Vitro: C25-140 dose-dependently impedes TRAF6-Ubc13 interaction.
C25-140 (10-30 μM; 2 hours) effectively reduces TRAF6-mediated ubiquitin chain formation.
C25-140 affects TNFα-induced phosphorylation of IκBα as well as NF-κB-induced target gene expression.
C25-140 efficiently inhibits IL-1β- and TNFα-mediated receptor signaling in the context of cytokine activation.

In Vivo: C25-140 (~1.5 mg/kg; topically to the shaved back and the right ear; twice daily for 6 days) ameliorates symptoms of autoimmune psoriasis in R 837-induced psoriasis mouse model.
C25-140 (6-14 mg/kg; given i.p.; twice daily for 14 days) shows a dose-dependent improvement of RA disease outcome in Collagen-induced arthritis (CIA) model.
C25-140 (10 mg/kg; i.v.) treatment shows that the C_max, AUC, t_1/2 and V_d are 9.7 μg/mL, 274083 ng min/mL, 80.62 min, and 4.13 L/kg, respectively.
.C25-140 (10 mg/kg; p.o.) treatment shows that the C_max, AUC, t_1/2 and V_d are 3.4 μg/mL, 124034 ng min/mL, 127.33 min and 13.3 L/kg, respectively.
C25-140 (10 mg/kg; i.p.) treatment shows that the C_max, AUC, t_1/2 and V_d are 4.2μg/mL, 100000 ng min/mL, 184 min, 25.6 L/kg, respectively.

相关产品：Bioactive Compound Library Plus  |  Apoptosis Compound Library  |  Immunology/Inflammation Compound Library  |  Metabolism/Protease Compound Library  |  NF-κB Signaling Compound Library  |  Differentiation Inducing Compound Library  |  Oxygen Sensing Compound Library  |  Ubiquitination Compound Library  |  Pyroptosis Compound Library  |  Resatorvid  |  Nutlin-3a  |  Shikonin  |  Fisetin  |  N-Formyl-Met-Leu-Phe  |  PYR-41  |  Adalimumab  |  BI8622  |  R-7050  |  Ginkgolic Acid  |  QNZ  |  SZL P1-41  |  2-D08  |  Infliximab  |  Indole-3-carbinol  |  NSC232003  |  BI8626  |  PRT4165  |  MI-773  |  Muscone  |  DKM 2-93  |  SPD304  |  Etanercept  |  Forsythoside B  |  Apratastat  |  Neochlorogenic acid  |  PYZD-4409  |  Ginsenoside Rh1

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。